Kcat’s Inception in Paris in EuroSciCon
Started Office in Co-working space – 3 Founders, just 2 Interns, No Employees, No Projects
Our dedicated Computational facility in Cox Town from co-working space
Kcat’s 7D Grid Technology was recognized as “Novel Tools in Enzyme Engineering” Enzyme Engg Consortium.
Pfizer visits Kcat’s Office in Cox Town
Kcat’s Molecular Biology Facility in Bangalore Bioinnovation Center
Kcat received the Prestigious BIRAC BIG Grant from the Dept. of Biotechnology, India.
Kcat receives 2 back-to-back UKRI Grants
Building of Enzyme Libraries – Engineered Enzyme Kits for diverse applications – Own Products
Hon’ble Finance Ministers Smt. Nirmala Seetharaman’s Visit
Established Fermentation Capabilities & gram scale protein production.
Kcat releases 7 products – Engineered Enzyme Kits for diverse biocatalysis applications
Supplied the Engineered Enzyme Kits to domestic and International Customers in Germany & UK
Kcat received the Prestigious National Institute of Health (NIH) – USA
Signed Contracts for Enzyme Manufacturing & Continuous Supply of Enzymes
Established manufacturing of Engineered Lipase through contract manufacturing mode at Kilogram scale.
Got some promising results in engineering flourinase – the toughest Enzyme Engineering Problem
KCAT Filed its First International Patent – 7D Grid & CRISPR Cas Technology
KCAT Published its research work in top journals in ACS Catalysis, Catalysis Today, Journal of Biological Chemistry
Automated Lab for Enzyme Screening
Kcat manuscript, “Structure dynamics and molecular inhibition of the Staphylococcus aureus m1A22-tRNA methyltransferase TrmK” has been selected as one of JBC’s “Editors Picks”.
Kcat is once again recognized by the “Enzyme Engineering Consortium”.
Texas Dallas/Fort Worth
Kcat Enzymatic has successfully secured its first investment from Ideaspring Capital, marking a significant milestone in our journey towards creating a sustainable future for a more resilient tomorrow.
We are extremely delighted to see you all at CPHI North America 2023. Come visit us at our booth #135.
Feel free to get in touch with us to discover how our state-of-the-art AI-powered technology can revolutionize your manufacturing process with novel biocatalytic routes.
We are extremely delighted to announce our latest research publication on “Modulation of Glucose 6 Phosphatase System by Chlorogenic Acids: A New Frontier in Diabetes Treatment.”
#kcat #newpublication #translocase
We’re excited to announce our latest publication in Nature Scientific Reports on proteins with double active sites, which could revolutionize enzyme design strategies. “Computational studies on the catalytic potential of the double active site for enzyme engineering”
We are extremely delighted to announce the granting of our patent “Insilico Guided CRISPR-Cas Driven Enzyme Engineering Framework.”
𝑨 𝑵𝒆𝒘 𝑷𝒓𝒐𝒕𝒆𝒊𝒏 𝑬𝒏𝒈𝒊𝒏𝒆𝒆𝒓𝒊𝒏𝒈 𝑻𝒐𝒐𝒍: 𝑬𝒏𝒈𝒊𝒏𝒆𝒆𝒓𝒆𝒅 𝑪𝑹𝑰𝑺𝑷𝑹-𝑪𝒂𝒔 𝑮𝒖𝒊𝒅𝒆𝒅 𝒃𝒚 𝑨𝑰 𝑫𝒆𝒔𝒊𝒈𝒏 𝒇𝒐𝒓 𝒆𝒏𝒈𝒊𝒏𝒆𝒆𝒓𝒊𝒏𝒈 𝒆𝒏𝒛𝒚𝒎𝒆𝒔.
Dramatically disseminate standardized metrics after resource-leveling processes. Objectively pursue diverse catalysts for change for services.
Michael Wright
Bello Servicing
Intrinsically incubate intuitive real time potentialities and opportunities communicate technology networks over time periods.
Daniel Huberth
Applauz
Globally harness multimedia based collaboration and idea-sharing with backend products opportunities via covalent scenarios.
John Strength
Avantage HR
Fabricate an expanded array of niche markets through robust products, implement visionary e-services vis-a-vis strategic readiness.
Mia McBride
Estato
Dramatically disseminate standardized metrics after resource-leveling processes. Objectively pursue diverse catalysts for change for services.
John Fox
Codiqa
Seamlessly empower fully researched growth strategies and interoperable internal or organic sources with optimal networks strategic web-readiness.
Hollie Neal
Nifty
Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.
Elsie Moore
Konstrakt